Athersys Stock Quote ATHX - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.1018

Bid

0.101

Ask

0.104

Volume

0.00 Day's Range 0.00

0.0938 52 Week Range 1.14

Market Cap

1.799M

Previous Close

0.1018

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

17,986,000

Dividend Yield

PE Ratio

-0.02

Earnings Per Share (EPS)

-4.03

Revenue

5.33M

Net Profit

-72.53M

Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are foc... Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.athersys.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Athersys Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ATHX. The last closing price for Athersys was $0.10. Over the last year, Athersys shares have traded in a share price range of $ 0.0938 to $ 1.14.

Athersys currently has 17,986,000 shares outstanding. The market capitalization of Athersys is $1.80 million. Athersys has a price to earnings ratio (PE ratio) of -0.02.

Form 8-K - Current report

Form 4 - Statement of changes in beneficial ownership of securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives

Athersys, Inc. (Nasdaq: ATHX), (“Athersys” or the “Company”) a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announces it has...

Form 8-K - Current report

Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios

The MOU includes $1.5M to $4.5M near term payments plus up to $150M in milestones Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem®...

Form 4 - Statement of changes in beneficial ownership of securities

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	-0.6993	-87.2924728498	0.8011	1.14	0.0938	2029513	0.16720661	CS
156	-41.8982	-99.7576190476	42	45.5	0.0938	2914002	11.462159	CS
260	-40.1482	-99.7470807453	40.25	110.5	0.0938	2576353	28.28035939	CS

Symbol	Price	Vol.
BDRXBiodexa Pharmaceuticals PLC	$ 1.22 (68.32%)	61.31M
NIVFNewGenIvf Group Ltd	$ 1.915 (47.31%)	53.29M
AWINAERWINS Technologies Inc	$ 3.39 (38.93%)	305.39k
ULHUniversal Logistics Holdings Inc	$ 45.24 (37.55%)	360.77k
AGENAgenus Inc	$ 11.2987 (36.13%)	1.84M
ISUNiSun Inc	$ 0.1579 (-95.42%)	8.39M
MFImF International Ltd	$ 1.78 (-82.95%)	16.5M
NWGLNature Wood Group Ltd	$ 5.0314 (-70.14%)	1.58M
ICLKiClick Interactive Asia Group Ltd	$ 1.24 (-50.99%)	631.25k
NUWENewellis Inc	$ 0.175 (-39.45%)	16.37M
PEGYPineapple Energy Inc	$ 0.0692 (33.33%)	281.02M
SQQQProShares UltraPro Short QQQ	$ 11.35 (-5.42%)	96.73M
INTCIntel Corporation	$ 31.585 (-10.04%)	80.12M
TSLATesla Inc	$ 171.54 (0.80%)	64.78M
BDRXBiodexa Pharmaceuticals PLC	$ 1.22 (68.32%)	61.31M

Symbol

Price

Vol.